Biofrontera Inc.
BFRI | NASDAQ
$1.16
-$0.16 (-12.12%)
At close: Sep 21, 2026, 4:00 PM ET
$1.20
+$0.04 (+3.45%)
After-hours:
Sep 21, 2026, 7:57 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 41.71M | 37.3M | 34.07M | 28.67M | 24.1M | 18.85M |
Cost of Revenue | 8.9M | 18.61M | 17.44M | 15.19M | 12.74M | 9.07M |
Gross Profit | 32.8M | 18.7M | 16.63M | 13.49M | 11.36M | 9.78M |
Operating Income | -9.15M | -17.21M | -22.68M | -18.58M | -25.2M | -9.61M |
Interest Income | n/a | 30K | 132K | 175K | 16K | 28K |
Pretax Income | -10.51M | -17.74M | -20.12M | -608K | -37.66M | -10.92M |
Net Income | -10.54M | -17.76M | -20.13M | -640K | -37.71M | -10.99M |
Selling & General & Admin | 38.13M | 33.84M | 39.13M | 35.87M | 37.21M | 18.12M |
Research & Development | 3.72M | 2.09M | 77K | n/a | n/a | n/a |
Other Expenses | 100K | n/a | 100K | -3.8M | -650K | 1.27M |
Operating Expenses | 41.95M | 35.92M | 39.3M | 32.07M | 36.56M | 19.39M |
Interest Expense | 452K | 2.11M | 600K | 370K | 360K | 2.9M |
Selling & Marketing Expenses | n/a | n/a | 1.43M | n/a | n/a | n/a |
Cost & Expenses | 50.85M | 54.53M | 56.75M | 47.26M | 49.3M | 28.46M |
Income Tax Expense | 25K | 22K | 14K | 32K | 56K | 64K |
Shares Outstanding (Basic) | 10.17M | 5.52M | 1.55M | 1.06M | 855.24K | 580K |
Shares Outstanding (Diluted) | 11.65M | 5.52M | 1.55M | 1.06M | 855.24K | 580K |
EPS (Basic) | -1.04 | -3.22 | -13.02 | -0.61 | -44.10 | -18.94 |
EPS (Diluted) | -0.90 | -3.22 | -13.02 | -0.61 | -44.10 | -18.94 |
EBITDA | -9.19M | -14.44M | -18.45M | 934K | -36.76M | -7.46M |
EBIT | -10.06M | -15.63M | -19.52M | -238K | -37.3M | -8.03M |
Depreciation & Amortization | 868K | 1.15M | 1.06M | 1.17M | 540K | 562K |
Add to Watchlist
Select watchlists to add or remove BFRI